Ritch N. Wood
Chief Executive Officer (CEO)
Ritch Wood was appointed Nu Skin’s chief executive officer in 2017. Previously, Wood served in various capacities at Nu Skin including chief financial officer, vice president of finance, vice president of new market development, director of finance of new market development and controller of the Pharmanex division. He also played a key role in opening many European countries for Nu Skin during an expatriate assignment from 1995 to 1997. Prior to his assignment in Europe, he served as the assistant director of international tax.
Wood worked for the international accounting firm of Grant Thornton prior to joining Nu Skin in 1993. He earned a Bachelor of Science and Master of Accountancy, taxation emphasis, from Brigham Young University and in 2010 was named a CFO of the Year by Utah Business magazine.
Ryan Napierski menjabat sebagai President of Global Sales and Operations setelah sebelumnya menduduki posisi President untuk Nu Skin Asia Utara dan President Nu Skin Jepang.Napierski pernah menjabat sebagai President Nu Skin Jepang dan Vice President of Business Development untuk kawasan Asia Utara. Ryan Napierski memiliki pengalaman di berbagai posisi sejak bergabung dengan Nu Skin tahun 1995, termasuk bertanggung jawab atas strategi perusahaan untuk pasar Jepang dan bertindak sebagai Vice President of Global Business Development untuk Corporate Distributor Success, General Manager untuk Inggris, Vice President of European Business Development serta Key Account Manager untuk para Executive Amerika Serikat. Napierski memiliki gelar sarjana bisnis serta master di bidang administrasi bisnis dari Duke University dan master di bidang bisnis internasional dari Goethe Universitas Jerman.
Joseph Y. Chang, Ph.D.
Chief Scientific Officer and Executive Vice President, Product Development
Joseph Y. Chang, Ph.D., was appointed Chief Scientific Officer and Executive Vice President of Product Development in February 2006. Dr. Chang enjoys a comprehensive knowledge of both the pharmaceutical and dietary supplement industries and serves as a member of the Executive Committee for Nu Skin Enterprises. He formerly served as president and chief scientific officer of Pharmanex. Prior to Pharmanex, Dr. Chang served as both president and chief scientific officer at Binary Therapeutics, Inc. from 1994 to 1997 and at OsteoArthritis Sciences, Inc. from 1991 to 1994. He has also held various executive research management positions at Wyeth-Ayerst, Rhone Poulenc Rorer and other biotechnology companies, where he was involved in researching natural products for arthritis and cancer treatment. A prolific author, Dr. Chang has published numerous articles, reviews and books on pharmacological research during his nearly 20 years in the health care industry. He received a B.S. degree from Portsmouth University and a Ph.D. from the University of London.
D. Matthew Dorny
Vice President, General Counsel and Secretary
D. Matthew Dorny was appointed General Counsel and Chief Legal Officer in March 2006. Prior to this appointment, he served as Vice President and General Counsel, and Assistant General Counsel for Nu Skin Enterprises. Prior to joining Nu Skin Enterprises, Mr. Dorny was a securities and business attorney in private practice. Mr. Dorny received a B.A., M.B.A. and J.D. degree from the University of Utah.